We’re improving your experience!

×

Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.

Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.

Stay tuned for these updates, and thank you for being part of our community!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04245397
Title SX-682 Treatment in Subjects With Myelodysplastic Syndrome Who Had Disease Progression or Are Intolerant to Prior Therapy
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Syntrix Biosystems, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic RECRUITING Jacksonville Florida 32224 United States Details
University of Miami RECRUITING Miami Florida 33136 United States Details
AdventHealth Medical Group & Bone Marrow Transplant at Orlando RECRUITING Orlando Florida 32804 United States Details
Moffitt Cancer Center RECRUITING Tampa Florida 33612 United States Details
Emory University RECRUITING Atlanta Georgia 30322 United States Details
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins RECRUITING Baltimore Maryland 21287 United States Details
Montefiore Medical Center RECRUITING Bronx New York 10467 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field